Fáilte chuig an Institiúid um Leigheas Athghiniúnach
Welcome to the Regenerative Medicine Institute (REMEDI®)

Dr. Xiaocai Sun

Postdoctoral Researcher

Novel models of schizophrenia

Researcher in

Research Project Area: 

The focus of Xiaocai’s research is the relationship between the AMPK family, especially ULK4, and other molecules and also iPS cells.

Positions Held: 

1995-2000 Bachelor's Degree of Medicine (Major in Clinical medicine), Hebei Medical University, China

2000-2003 Master's Degree of Medicine (Major in pathophysiology), Hebei Medical University, China

2003-2006 Doctor's Degree of Medicine (Major in physiology), Hebei Medical University, China

2006-2012 Faculty member, Associated Professor, Department of Pathophysiology, Hebei Medical
University, China

Feb. 2012-present Postdoctoral Researcher, Regenerative Medicine Institute (REMEDI), NUI, Galway
 

Awards & Honours: 

1) Oct. 2005 Hebei Science and Technology Progress Award

2) Jul. 2006 Best Poster Contribution on the 5th international Congress of Pathophysiology
 

Selected Publications: 

1) Sun XC, Xian XH, Li WB, et al. Activation of p38 MAPK participates in the brain ischemic tolerance induced by limb ischemic preconditioning through up-regulating HSP 70. Exp Neurol, 2010, 224(2):347-355

2) Sun XC, Chen WN, Li SQ, et al. Fluorocitrate, an inhibitor of glial metabolism, inhibits the up-regulation of NOS expression, activity and NO production in the spinal cord induced by formalin test in rats. Neurochem Res, 2009, 34(2):351-359

3) Sun XC, Li WB, Li QJ, et al. Limb ischemic preconditioning induces brain ischemic tolerance via p38 MAPK. Brain Res, 2006, 1084(1):165-174

4) SUN Xiao-cai, LI Li, ZHANG Min, et al. Division of CA1, CA3 and DG regions of the hippocampus of Wistar rat. Zhongguo Ying Yong Sheng Li Xue Za Zhi, 2012,28(2):189-192

5) Sun XC, Li WB, Li QJ, et al. P38 MAPK antisense oligodeoxynucleotide inhibited the brain ischemic tolerance induced by limb ischemic preconditioning. Zhongguo Ying Yong Sheng Li Xue Za Zhi, 2010, 26(2): 129-132.
 

Research Funding: 

1) The neural and humoral pathways in brain protection and up-regulation of p38 MAPK and ERK induced by limb ischemic preconditioning

(National Natural Science Foundation of China, 2012.1-2014.12, Principal investigator)

2) Activation of p38 MAPK participates in the brain ischemic tolerance induced by limb ischemic preconditioning through up-regulating GLT-1

(Natural Science Foundation of Hebei Province, P.R. China, 2011-2013, Principal investigator)

3) The neural and humoral pathways in brain protection and up-regulation of p38 MAPK and ERK induced by limb ischemic preconditioning

(Key project of Science and Technology studies of Hebei institution of higher education, 2011-2013, Principal investigator)

4) P38 MAPK up-regulates HSP 70 in the brain ischemic tolerance induced by limb ischemic preconditioning

(Hebei province Science & Technology Pillar Program, 2007-2009, Principal investigator)

5) Study of the relationship between p38 MAPK and HSP 70 in brain ischemic tolerance induced by limb ischemic preconditioning

(Foundation of scientific backbone breeding plan of Hebei Medical University, 2007-2009, Principal investigator)